Advertisement

Topics

Boston Biotech Conferences, LLC Company Profile

15:24 EST 15th December 2018 | BioPortfolio


News Articles [2240 Associated News Articles listed on BioPortfolio]

Boston Biotech Conferences Announces the Appointment of Xconomy Founder Bob Buderi as Chairman

Buderi brings decades of experience with biotech and biopharma that will help connect attendees to an extensive network of industry experts. BOSTON (PRWEB) September 05, 2018 Boston Biotech Conferenc...

George Golumbeski, President of GRAIL, Inc. to Deliver Keynote at BD Boston 2018

This peer-to-peer meeting provides an opportunity for industry leaders to leverage insight from real-life business development experiences and dissect the most relevant deals in biotech. BOSTON (PRWEB...

Newly Appointed CEO, Wendy Nelson, PhD, Leads Boston Biotech Conferences in a New Direction

Nelson has over 20 years of business development, project management, operational and research and development experience in the industry and is also President and Founder of the Boston Biotech Forum ...

EDB Group: Carola Schropp on the Role of EBD Group conferences in partnering and deal making

In this episode of PharmaTelevsion News Review, Fintan Walton discusses the recent BioPharm America conference in Boston with Carola Schropp from the EBD Group. • Role of EBD Group conferences in p...

#jobs #lifescience Recent Graduates Apply! Receptionist/Admin Needed at Boston Biotech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Recent Graduates Apply! Receptionist/Admin Needed at Boston Biotech .MA-Cambr...

The latest updates from Biotech Week Boston

BioProcess International has kicked off at Biotech Week Boston. BioPharma-Reporter is here to cover the best of the sessions and the reactions from everyone present.

Don’t Be Boston 2.0, And Photos From “Bringing Back the Expats”

Be your own biotech cluster, not a Boston redux. Accelerate the momentum that’s already begun, don’t let it fizzle. And above all, be fearless entrepreneurs. You’ll need to be if New York biotec...

Announcing Jeremy Levin, CEO of Ovid Therapeutics, as the Keynote Speaker for NY/NJ CEO 2018

This peer-to-peer meeting provides an opportunity to find new partners and refresh established relationships by getting access to thought leaders in the New York and New Jersey biopharma community. NE...

PubMed Articles [114 Associated PubMed Articles listed on BioPortfolio]

Boston type I keratoprosthesis implantation technique : Video article.

Keratoprosthetics refer to the replacement of human corneal tissue with an artificially produced exchange product. The most widely implanted keratoprosthesis worldwide is the Boston Type I Keratopros...

A Seat at the Table: The Positioning of Families During Care Conferences in Nursing Homes.

Current nursing home policy emphasizes the need for collaborative, team-based care planning in which families and/or residents are actively involved. Resident care conferences are common where care pr...

Morbidity and mortality conferences : Structure and clinical experiences.

Morbidity and mortality conferences (M & M) have become increasingly more important in Germany in recent years as an important risk management tool; however, in addition to risk identification M &...

Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.

To compare the outcomes of Boston keratoprosthesis type 1 implantation after failed keratoplasty in patients who are blind or sighted in the contralateral eye.

Case conferences for infective endocarditis: A quality improvement initiative.

A multidisciplinary approach has been recommended for the management of patients with infective endocarditis. We evaluated the impact of multidisciplinary case conferences on morbidity, mortality, and...

Clinical Trials [230 Associated Clinical Trials listed on BioPortfolio]

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

Intervention of Psychological and Ethical Professionals of Human Science in Obstetrical Morbidity and Mortality Conferences (OPEN : Organization, Practices Evaluation in Perinatal Network)

This cluster-randomised controlled trial will test the hypothesis that a multifaceted program with psychological intervention in morbidity mortality conferences (MMC) improve care quality ...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Companies [1529 Associated Companies listed on BioPortfolio]

Boston Biotech Conferences, LLC

GeneExpression Systems, Inc.

GeneExpression Systems, Inc. is a biotech company that develops and markets differential gene profiling technology for down stream study of gene expression, regulation, diagnostic, predictive toxicolo...

International Business Forum, Inc.

IBF*International Business Forum, Inc. is a leading presenter of venture capital, technology innovation and private equity conferences in the United States. For 20 years, IBF has been presenting confe...

CBI Research, Inc

Founded in 1994 in Boston, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticals, biotech, medical devices, risk and insurance and managed care markets. ...

Boston Biomedical, Inc.

Boston Biomedical, Inc. (Founder, Chairman, CEO and CMO: Chiang J. Li, M.D. FACP) was founded in November, 2006 and is a privately-held biotechnology company focused on the resear...

More Information about "Boston Biotech Conferences, LLC" on BioPortfolio

We have published hundreds of Boston Biotech Conferences, LLC news stories on BioPortfolio along with dozens of Boston Biotech Conferences, LLC Clinical Trials and PubMed Articles about Boston Biotech Conferences, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boston Biotech Conferences, LLC Companies in our database. You can also find out about relevant Boston Biotech Conferences, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record